Delayed diagnosis of severe diabetic ketoacidosis associated with a sodium-glucose cotransporter 2 inhibitor: a case report

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are used to treat patients with type 2 diabetes mellitus but may induce diabetic ketoacidosis (DKA). Owing to their pharmacological mechanisms, they cause a different pathogenesis to that of typical DKA and require special attention in terms of blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniguchi, Hiroaki, Terayama, Takero, Seno, Soichiro, Kiriu, Nobuaki, Kato, Hiroshi, Sekine, Yasumasa, Kiyozumi, Tetsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359057/
https://www.ncbi.nlm.nih.gov/pubmed/37484556
http://dx.doi.org/10.1093/omcr/omad074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359057/
https://www.ncbi.nlm.nih.gov/pubmed/37484556
http://dx.doi.org/10.1093/omcr/omad074

Ejemplares similares